Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	54.73	-6.50	-14.37
Graham Fair Price	33.74	0.41	0.30
PEG	98.34	-0.01	-0.85
Price/Book	-0.89	5.34	5.39
Price/Cash Flow	100.00	48.95	0.00
Prices/Earnings	55.64	-1.41	-3.18
Price/Sales	-55.64	5.42	12.23
Price/FCF	100.00	48.95	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	-0.52	-0.52
Operating Margin	-0.76	-0.92	-0.91
ROA	-100.00	-0.33	-0.17
ROE	-0.42	-0.95	-123.41
ROIC	-0.31	-0.63	-99.70
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.38	-0.31	20.37
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	< 0.005	-1.02	-16938.33
EPS QOQ	-0.04	-1.00	-2573.57
FCF QOQ	1.00	0.00	inf
Revenue QOQ	-0.34	1.00	192.03
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	128.02	64.01	-50.00
Days Sales Outstanding (DSO)	100.74	50.37	-50.00
Inventory Turnover	0.70	1.41	100.00
Debt/Capitalization	0.22	0.30	37.22
Quick Ratio	0.43	0.43	0.08
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.10	0.09	-10.52
Cash	0.01	0.01	0.30
Capex	0.00	< 0.005	-100.00
Free Cash Flow	0.00	< 0.005	100.00
Revenue	0.04	0.09	99.91
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.08	1.08	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.38	-0.33	14.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating